Csf1r binding agents
A R-A-S-Q-S-V-X1-Y-X2-G-X3-N-Y-L-X4, X1-A-S-X2-X3-X4-T technology, applied in the field of CSF1R binding agent, can solve the problem of unsatisfactory humanized form
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0374] Example 1: Generation of optimized anti-CSF1R therapeutic antibodies
[0375] introduce
[0376] In this example, a panel of optimized agonistic anti-CSF1R antibodies was successfully generated. These anti-CSF1R antibodies are well expressed, biophysically stable, highly soluble and have the highest identity to the preferred human germline.
[0377] Materials and methods
[0378] CSF1R library generation and selection
[0379] The CSF1R Fab library was assembled by large-scale oligonucleotide synthesis and PCR. The amplified Fab pool was then cloned into a phagemid vector by restriction-ligation, transformed into E. coli TG-1 cells, and the phage pool was rescued essentially as previously described in detail (Finlay et al., 2011, Methods Mol Biol. 681:383-401).
[0380] Phage selection was performed by coating streptavidin magnetic beads with biotinylated CSF1R target protein (human or cynomolgus monkey), washing the beads three times with PBS and resuspending ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com